Literature DB >> 19246710

Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis.

H Christian Schumacher1, Philip M Meyers, Randall T Higashida, Colin P Derdeyn, Sean D Lavine, Gary M Nesbit, David Sacks, Peter Rasmussen, Lawrence R Wechsler.   

Abstract

BACKGROUND AND
PURPOSE: Intracranial cerebral atherosclerosis causes ischemic stroke in a significant number of patients. Technological advances over the past 10 years have enabled endovascular treatment of intracranial atherosclerotic stenosis. The number of patients treated with angioplasty or stent-assisted angioplasty for this condition is increasing. Given the lack of universally accepted definitions, the goal of this document is to provide consensus recommendations for reporting standards, terminology, and written definitions when reporting clinical and radiological evaluation, technique, and outcome of endovascular treatment using angioplasty or stent-assisted angioplasty for stenotic and occlusive intracranial atherosclerosis. SUMMARY OF REPORT: This article was written under the auspices of Joint Writing Group of the Technology Assessment Committee, Society of NeuroInterventional Surgery, Society of Interventional Radiology; Joint Section on Cerebrovascular Neurosurgery of the American Association of Neurological Surgeons and Congress of Neurological Surgeons; and the Section of Stroke and Interventional Neurology of the American Academy of Neurology. A computerized search of the National Library of Medicine database of literature (PubMed) from January 1997 to December 2007 was conducted with the goal to identify published endovascular cerebrovascular interventional data in stenotic intracranial atherosclerosis that could be used as benchmarks for quality assessment. We sought to identify those risk adjustment variables that affect the likelihood of success and complications. This document offers the rationale for different clinical and technical considerations that may be important during the design of clinical trials for endovascular treatment of intracranial stenotic and occlusive atherosclerosis. Included in this guidance document are suggestions for uniform reporting standards for such trials. These definitions and standards are primarily intended for research purposes; however, they should also be helpful in clinical practice and applicable to all publications.
CONCLUSIONS: In summary, the definitions proposed represent recommendations for constructing useful research data sets. The intent is to facilitate production of scientifically rigorous results capable of reliable comparisons between and among similar studies. In some cases, the definitions contained here are recommended by consensus of a panel of experts in this writing group for consistency in reporting and publication. These definitions should allow different groups to publish results that are directly comparable.

Entities:  

Mesh:

Year:  2009        PMID: 19246710     DOI: 10.1161/STROKEAHA.108.527580

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Value of imaging lenticulostriate arteries before middle cerebral artery stenting for the prevention of perforator stroke.

Authors:  Jian-Ren Liu; Min Zhang; Meng-Li Wei
Journal:  Neuroradiology       Date:  2012-07-10       Impact factor: 2.804

Review 2.  Point-of-care testing for anticoagulation monitoring in neuroendovascular procedures.

Authors:  H M Hussein; A L Georgiadis; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

3.  Implication of cerebral circulation time in intracranial stenosis measured by digital subtraction angiography on cerebral blood flow estimation measured by arterial spin labeling.

Authors:  Kay Jann; Martinus Hauf; Frauke Kellner Weldon; Marwan El Koussy; Claus Kiefer; Andrea Federspiel; Gerhard Schroth
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

4.  Impact of Target Arterial Residual Stenosis on Outcome After Endovascular Revascularization.

Authors:  Yang-Ha Hwang; Yong-Won Kim; Dong-Hun Kang; Yong-Sun Kim; David S Liebeskind
Journal:  Stroke       Date:  2016-05-12       Impact factor: 7.914

5.  Stenting versus medical treatment for severe symptomatic intracranial stenosis.

Authors:  C-W Tang; F-C Chang; C-M Chern; Y-C Lee; H-H Hu; I-H Lee
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-10       Impact factor: 3.825

6.  Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue): procedural safety, efficacy, and midterm patency.

Authors:  Zsolt Vajda; Elina Miloslavski; Thomas Güthe; Elisabeth Schmid; Christoph Schul; Guido Albes; Hans Henkes
Journal:  Neuroradiology       Date:  2009-11-17       Impact factor: 2.804

7.  Fluid-attenuated inversion recovery hyperintense vessels in posterior cerebral artery infarction.

Authors:  Kwon-Duk Seo; Kee Oog Lee; Young-Chul Choi; Won-Joo Kim; Kyung-Yul Lee
Journal:  Cerebrovasc Dis Extra       Date:  2013-04-05

8.  Safety of low-dose aspirin in endovascular treatment for intracranial atherosclerotic stenosis.

Authors:  Ning Ma; Ziqi Xu; Dapeng Mo; Feng Gao; Kun Gao; Xuan Sun; Xiaotong Xu; Lian Liu; Ligang Song; Tiejun Wang; Xingquan Zhao; Yilong Wang; Yongjun Wang; Zhongrong Miao
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

9.  Relationship between deep medullary veins in susceptibility-weighted imaging and ipsilateral cerebrovascular reactivity of middle cerebral artery in patients with ischemic stroke.

Authors:  Xianjun Han; Linhui Ouyang; Chunning Zhang; Hailing Ma; Jingcui Qin
Journal:  Exp Ther Med       Date:  2016-03-28       Impact factor: 2.447

10.  Higher Levels of Cystatin C Are Associated with Extracranial Carotid Artery Steno-Occlusive Disease in Patients with Noncardioembolic Ischemic Stroke.

Authors:  Toshitaka Umemura; Takahiko Kawamura; Shinichi Mashita; Takashi Kameyama; Gen Sobue
Journal:  Cerebrovasc Dis Extra       Date:  2016-01-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.